Endogenous antibody responsiveness to epidermal growth factor receptor is associated with immunoglobulin allotypes and overall survival of patients with glioblastoma-Reference-Cited by-同舟云学术

Endogenous antibody responsiveness to epidermal growth factor receptor is associated with immunoglobulin allotypes and overall survival of patients with glioblastoma

Published:2014-10-17 Issue:5 Volume:17 Page:678-684
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro-Oncology

Author:

Pandey J. P.,Kistner-Griffin E.,Radwan F. F.,Kaur N.,Namboodiri A. M.,Black L.,Butler M. A.,Carreon T.,Ruder A. M.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/17/5/678/7639889/nou298.pdf

Reference35 articles.

1. Prognostic Effect of Epidermal Growth Factor Receptor and EGFRvIII in Glioblastoma Multiforme Patients

2. Therapeutic targeting of EGFR in malignant gliomas

3. Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines

4. The forgotten tale of immunoglobulin allotypes in cancer risk and treatment

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Significance of Key Proteins in the RAS Signaling Pathway: Implications for Cancer and Therapeutic Targets;OBM Genetics;2024-05-24

2. Dendritic Cell Therapy;eLS;2018-06-14

3. Peripheral White Blood Cell Subsets in Metastatic Colorectal Cancer Patients Treated with Cetuximab: The Potential Clinical Relevance;Frontiers in Immunology;2018-01-04

4. Allotypes ☆;Reference Module in Life Sciences;2017

5. Immune Responses to Epidermal Growth Factor Receptor (EGFR) and Their Application for Cancer Treatment;Frontiers in Pharmacology;2016-10-26